According to their involvement in a wide range of metabolic processes, wild-type IDH-mediated metabolic reprogramming could also be a key driver of tumor adaptation allowing GBM proliferation, tumor escape, and recurrence. The gene discussed is IDH1; the disease is glioblastoma.